nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—systemic scleroderma—systemic lupus erythematosus	0.155	0.306	CtDrD
Methotrexate—ankylosing spondylitis—systemic lupus erythematosus	0.132	0.261	CtDrD
Methotrexate—rheumatoid arthritis—systemic lupus erythematosus	0.119	0.235	CtDrD
Methotrexate—psoriasis—systemic lupus erythematosus	0.0997	0.197	CtDrD
Methotrexate—ALB—systemic lupus erythematosus	0.0543	1	CbGaD
Methotrexate—ABCC10—Cyclosporine—systemic lupus erythematosus	0.0292	0.11	CbGbCtD
Methotrexate—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.0215	0.0808	CbGbCtD
Methotrexate—ABCC3—Cyclosporine—systemic lupus erythematosus	0.0184	0.069	CbGbCtD
Methotrexate—ABCG2—Leflunomide—systemic lupus erythematosus	0.0161	0.0605	CbGbCtD
Methotrexate—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0125	0.0471	CbGbCtD
Methotrexate—ABCC1—Cyclosporine—systemic lupus erythematosus	0.0113	0.0424	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—systemic lupus erythematosus	0.0112	0.0422	CbGbCtD
Methotrexate—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.011	0.0414	CbGbCtD
Methotrexate—SLCO1A2—Hydrocortisone—systemic lupus erythematosus	0.0107	0.04	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—systemic lupus erythematosus	0.0106	0.0399	CbGbCtD
Methotrexate—SLCO1A2—Cyclosporine—systemic lupus erythematosus	0.0101	0.0378	CbGbCtD
Methotrexate—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.00995	0.0374	CbGbCtD
Methotrexate—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.00949	0.0357	CbGbCtD
Methotrexate—ABCC2—Cyclosporine—systemic lupus erythematosus	0.00834	0.0314	CbGbCtD
Methotrexate—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.00799	0.03	CbGbCtD
Methotrexate—ABCG2—Cyclosporine—systemic lupus erythematosus	0.00754	0.0283	CbGbCtD
Methotrexate—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.00686	0.0258	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—systemic lupus erythematosus	0.00663	0.0249	CbGbCtD
Methotrexate—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0061	0.0229	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—systemic lupus erythematosus	0.00549	0.0206	CbGbCtD
Methotrexate—ALB—Prednisone—systemic lupus erythematosus	0.00548	0.0206	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00497	0.0187	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00473	0.0178	CbGbCtD
Methotrexate—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00359	0.0135	CbGbCtD
Methotrexate—ABCB1—Betamethasone—systemic lupus erythematosus	0.00308	0.0116	CbGbCtD
Methotrexate—ABCB1—Prednisolone—systemic lupus erythematosus	0.00304	0.0114	CbGbCtD
Methotrexate—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00288	0.0108	CbGbCtD
Methotrexate—ABCB1—Prednisone—systemic lupus erythematosus	0.00287	0.0108	CbGbCtD
Methotrexate—SLC22A8—choroid plexus—systemic lupus erythematosus	0.00282	0.062	CbGeAlD
Methotrexate—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00272	0.0102	CbGbCtD
Methotrexate—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00179	0.00673	CbGbCtD
Methotrexate—ATIC—blood plasma—systemic lupus erythematosus	0.000866	0.019	CbGeAlD
Methotrexate—FOLR1—nephron tubule—systemic lupus erythematosus	0.00079	0.0174	CbGeAlD
Methotrexate—SLC22A8—urine—systemic lupus erythematosus	0.000756	0.0166	CbGeAlD
Methotrexate—FOLR1—kidney—systemic lupus erythematosus	0.000694	0.0153	CbGeAlD
Methotrexate—FOLR1—cortex of kidney—systemic lupus erythematosus	0.000676	0.0149	CbGeAlD
Methotrexate—MTHFR—blood plasma—systemic lupus erythematosus	0.000643	0.0141	CbGeAlD
Methotrexate—FOLR1—lymphoid tissue—systemic lupus erythematosus	0.000597	0.0131	CbGeAlD
Methotrexate—PGD—blood plasma—systemic lupus erythematosus	0.000559	0.0123	CbGeAlD
Methotrexate—GGH—nephron tubule—systemic lupus erythematosus	0.000525	0.0115	CbGeAlD
Methotrexate—SLC19A1—lymphoid tissue—systemic lupus erythematosus	0.000523	0.0115	CbGeAlD
Methotrexate—SLCO1B1—blood plasma—systemic lupus erythematosus	0.000508	0.0111	CbGeAlD
Methotrexate—FOLR1—lung—systemic lupus erythematosus	0.000492	0.0108	CbGeAlD
Methotrexate—GGH—skin of body—systemic lupus erythematosus	0.00049	0.0108	CbGeAlD
Methotrexate—ABCC3—blood plasma—systemic lupus erythematosus	0.000482	0.0106	CbGeAlD
Methotrexate—FPGS—connective tissue—systemic lupus erythematosus	0.000477	0.0105	CbGeAlD
Methotrexate—SLCO4C1—nephron tubule—systemic lupus erythematosus	0.000466	0.0102	CbGeAlD
Methotrexate—GGH—kidney—systemic lupus erythematosus	0.000462	0.0101	CbGeAlD
Methotrexate—ATIC—connective tissue—systemic lupus erythematosus	0.000461	0.0101	CbGeAlD
Methotrexate—GGH—cortex of kidney—systemic lupus erythematosus	0.000449	0.00987	CbGeAlD
Methotrexate—FOLR1—central nervous system—systemic lupus erythematosus	0.000439	0.00964	CbGeAlD
Methotrexate—SLC19A1—lung—systemic lupus erythematosus	0.000432	0.00948	CbGeAlD
Methotrexate—FPGS—skin of body—systemic lupus erythematosus	0.00043	0.00945	CbGeAlD
Methotrexate—ATIC—skin of body—systemic lupus erythematosus	0.000416	0.00914	CbGeAlD
Methotrexate—SLCO4C1—kidney—systemic lupus erythematosus	0.000409	0.00899	CbGeAlD
Methotrexate—SLC46A1—lymphoid tissue—systemic lupus erythematosus	0.000403	0.00885	CbGeAlD
Methotrexate—SLC19A1—nervous system—systemic lupus erythematosus	0.0004	0.00878	CbGeAlD
Methotrexate—SLCO4C1—cortex of kidney—systemic lupus erythematosus	0.000399	0.00876	CbGeAlD
Methotrexate—ABCC4—blood plasma—systemic lupus erythematosus	0.000398	0.00873	CbGeAlD
Methotrexate—FPGS—cortex of kidney—systemic lupus erythematosus	0.000395	0.00868	CbGeAlD
Methotrexate—ATIC—kidney—systemic lupus erythematosus	0.000392	0.00862	CbGeAlD
Methotrexate—SLC19A1—central nervous system—systemic lupus erythematosus	0.000385	0.00845	CbGeAlD
Methotrexate—SLC46A1—tendon—systemic lupus erythematosus	0.000379	0.00832	CbGeAlD
Methotrexate—GGH—tendon—systemic lupus erythematosus	0.000373	0.00819	CbGeAlD
Methotrexate—GGH—bone marrow—systemic lupus erythematosus	0.000361	0.00793	CbGeAlD
Methotrexate—SLC22A11—nephron tubule—systemic lupus erythematosus	0.000361	0.00792	CbGeAlD
Methotrexate—FPGS—lymphoid tissue—systemic lupus erythematosus	0.000348	0.00765	CbGeAlD
Methotrexate—SLC22A6—nephron tubule—systemic lupus erythematosus	0.00034	0.00746	CbGeAlD
Methotrexate—ATIC—lymphoid tissue—systemic lupus erythematosus	0.000337	0.0074	CbGeAlD
Methotrexate—FPGS—tendon—systemic lupus erythematosus	0.000328	0.0072	CbGeAlD
Methotrexate—GGH—lung—systemic lupus erythematosus	0.000327	0.00718	CbGeAlD
Methotrexate—SLCO1C1—kidney—systemic lupus erythematosus	0.000326	0.00717	CbGeAlD
Methotrexate—SLCO4C1—bone marrow—systemic lupus erythematosus	0.00032	0.00703	CbGeAlD
Methotrexate—SLC22A11—kidney—systemic lupus erythematosus	0.000317	0.00696	CbGeAlD
Methotrexate—TYMS—connective tissue—systemic lupus erythematosus	0.000313	0.00687	CbGeAlD
Methotrexate—DHFR—connective tissue—systemic lupus erythematosus	0.00031	0.0068	CbGeAlD
Methotrexate—SLC22A7—kidney—systemic lupus erythematosus	0.000309	0.00679	CbGeAlD
Methotrexate—SLC22A11—cortex of kidney—systemic lupus erythematosus	0.000309	0.00678	CbGeAlD
Methotrexate—SLC46A1—nervous system—systemic lupus erythematosus	0.000308	0.00676	CbGeAlD
Methotrexate—TYMS—nephron tubule—systemic lupus erythematosus	0.000303	0.00665	CbGeAlD
Methotrexate—GGH—nervous system—systemic lupus erythematosus	0.000303	0.00665	CbGeAlD
Methotrexate—SLC22A7—cortex of kidney—systemic lupus erythematosus	0.000301	0.00662	CbGeAlD
Methotrexate—DHFR—nephron tubule—systemic lupus erythematosus	0.0003	0.00659	CbGeAlD
Methotrexate—PGD—connective tissue—systemic lupus erythematosus	0.000298	0.00654	CbGeAlD
Methotrexate—SLC46A1—central nervous system—systemic lupus erythematosus	0.000296	0.00651	CbGeAlD
Methotrexate—GGH—central nervous system—systemic lupus erythematosus	0.000292	0.0064	CbGeAlD
Methotrexate—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000291	0.00639	CbGeAlD
Methotrexate—SLCO4C1—lung—systemic lupus erythematosus	0.00029	0.00637	CbGeAlD
Methotrexate—PGD—nephron tubule—systemic lupus erythematosus	0.000288	0.00633	CbGeAlD
Methotrexate—FPGS—lung—systemic lupus erythematosus	0.000287	0.00631	CbGeAlD
Methotrexate—SLCO3A1—kidney—systemic lupus erythematosus	0.000287	0.0063	CbGeAlD
Methotrexate—TYMS—skin of body—systemic lupus erythematosus	0.000282	0.0062	CbGeAlD
Methotrexate—SLCO1B3—lung—systemic lupus erythematosus	0.000282	0.00619	CbGeAlD
Methotrexate—SLCO3A1—cortex of kidney—systemic lupus erythematosus	0.000279	0.00614	CbGeAlD
Methotrexate—ATIC—lung—systemic lupus erythematosus	0.000278	0.00611	CbGeAlD
Methotrexate—PGD—skin of body—systemic lupus erythematosus	0.000269	0.0059	CbGeAlD
Methotrexate—FPGS—nervous system—systemic lupus erythematosus	0.000266	0.00585	CbGeAlD
Methotrexate—DHFR—kidney—systemic lupus erythematosus	0.000263	0.00579	CbGeAlD
Methotrexate—TYMS—cortex of kidney—systemic lupus erythematosus	0.000259	0.00569	CbGeAlD
Methotrexate—ATIC—nervous system—systemic lupus erythematosus	0.000257	0.00566	CbGeAlD
Methotrexate—DHFR—cortex of kidney—systemic lupus erythematosus	0.000257	0.00564	CbGeAlD
Methotrexate—FPGS—central nervous system—systemic lupus erythematosus	0.000256	0.00563	CbGeAlD
Methotrexate—AOX1—nephron tubule—systemic lupus erythematosus	0.000254	0.00558	CbGeAlD
Methotrexate—PGD—kidney—systemic lupus erythematosus	0.000253	0.00556	CbGeAlD
Methotrexate—MTHFR—lymphoid tissue—systemic lupus erythematosus	0.000251	0.0055	CbGeAlD
Methotrexate—ATIC—central nervous system—systemic lupus erythematosus	0.000248	0.00545	CbGeAlD
Methotrexate—PGD—cortex of kidney—systemic lupus erythematosus	0.000247	0.00542	CbGeAlD
Methotrexate—SLC16A1—kidney—systemic lupus erythematosus	0.000236	0.00519	CbGeAlD
Methotrexate—SLCO3A1—tendon—systemic lupus erythematosus	0.000232	0.00509	CbGeAlD
Methotrexate—SLCO1B1—kidney—systemic lupus erythematosus	0.00023	0.00505	CbGeAlD
Methotrexate—TYMS—lymphoid tissue—systemic lupus erythematosus	0.000229	0.00502	CbGeAlD
Methotrexate—DHFR—lymphoid tissue—systemic lupus erythematosus	0.000226	0.00497	CbGeAlD
Methotrexate—AOX1—kidney—systemic lupus erythematosus	0.000223	0.0049	CbGeAlD
Methotrexate—ABCC3—kidney—systemic lupus erythematosus	0.000218	0.00479	CbGeAlD
Methotrexate—PGD—lymphoid tissue—systemic lupus erythematosus	0.000218	0.00478	CbGeAlD
Methotrexate—AOX1—cortex of kidney—systemic lupus erythematosus	0.000217	0.00477	CbGeAlD
Methotrexate—ABCC10—kidney—systemic lupus erythematosus	0.000217	0.00477	CbGeAlD
Methotrexate—TYMS—tendon—systemic lupus erythematosus	0.000215	0.00472	CbGeAlD
Methotrexate—SLCO1C1—nervous system—systemic lupus erythematosus	0.000214	0.0047	CbGeAlD
Methotrexate—DHFR—tendon—systemic lupus erythematosus	0.000213	0.00467	CbGeAlD
Methotrexate—ABCC10—cortex of kidney—systemic lupus erythematosus	0.000212	0.00465	CbGeAlD
Methotrexate—TYMS—bone marrow—systemic lupus erythematosus	0.000208	0.00457	CbGeAlD
Methotrexate—MTHFR—lung—systemic lupus erythematosus	0.000207	0.00454	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—systemic lupus erythematosus	0.000206	0.00453	CbGeAlD
Methotrexate—DHFR—bone marrow—systemic lupus erythematosus	0.000206	0.00453	CbGeAlD
Methotrexate—ABCC4—nephron tubule—systemic lupus erythematosus	0.000205	0.0045	CbGeAlD
Methotrexate—PGD—tendon—systemic lupus erythematosus	0.000205	0.00449	CbGeAlD
Methotrexate—SLC22A8—nephron tubule—systemic lupus erythematosus	0.000203	0.00447	CbGeAlD
Methotrexate—SLCO3A1—lung—systemic lupus erythematosus	0.000203	0.00447	CbGeAlD
Methotrexate—ABCC2—nephron tubule—systemic lupus erythematosus	0.000198	0.00436	CbGeAlD
Methotrexate—PGD—bone marrow—systemic lupus erythematosus	0.000198	0.00435	CbGeAlD
Methotrexate—MTHFR—nervous system—systemic lupus erythematosus	0.000191	0.0042	CbGeAlD
Methotrexate—SLC16A1—tendon—systemic lupus erythematosus	0.000191	0.00419	CbGeAlD
Methotrexate—TYMS—lung—systemic lupus erythematosus	0.000189	0.00414	CbGeAlD
Methotrexate—SLCO3A1—nervous system—systemic lupus erythematosus	0.000188	0.00414	CbGeAlD
Methotrexate—SLCO1A2—kidney—systemic lupus erythematosus	0.000187	0.00411	CbGeAlD
Methotrexate—DHFR—lung—systemic lupus erythematosus	0.000187	0.0041	CbGeAlD
Methotrexate—ABCC10—lymphoid tissue—systemic lupus erythematosus	0.000187	0.0041	CbGeAlD
Methotrexate—MTHFR—central nervous system—systemic lupus erythematosus	0.000184	0.00405	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—systemic lupus erythematosus	0.000181	0.00398	CbGeAlD
Methotrexate—AOX1—tendon—systemic lupus erythematosus	0.00018	0.00396	CbGeAlD
Methotrexate—ABCC4—kidney—systemic lupus erythematosus	0.00018	0.00396	CbGeAlD
Methotrexate—PGD—lung—systemic lupus erythematosus	0.000179	0.00394	CbGeAlD
Methotrexate—SLC22A8—kidney—systemic lupus erythematosus	0.000179	0.00393	CbGeAlD
Methotrexate—ABCC4—cortex of kidney—systemic lupus erythematosus	0.000175	0.00385	CbGeAlD
Methotrexate—ABCC10—tendon—systemic lupus erythematosus	0.000175	0.00385	CbGeAlD
Methotrexate—TYMS—nervous system—systemic lupus erythematosus	0.000175	0.00384	CbGeAlD
Methotrexate—ABCC2—kidney—systemic lupus erythematosus	0.000174	0.00383	CbGeAlD
Methotrexate—SLC22A8—cortex of kidney—systemic lupus erythematosus	0.000174	0.00382	CbGeAlD
Methotrexate—DHFR—nervous system—systemic lupus erythematosus	0.000173	0.0038	CbGeAlD
Methotrexate—ABCC10—bone marrow—systemic lupus erythematosus	0.00017	0.00373	CbGeAlD
Methotrexate—ABCC2—cortex of kidney—systemic lupus erythematosus	0.00017	0.00373	CbGeAlD
Methotrexate—TYMS—central nervous system—systemic lupus erythematosus	0.000168	0.00369	CbGeAlD
Methotrexate—SLC16A1—lung—systemic lupus erythematosus	0.000168	0.00368	CbGeAlD
Methotrexate—DHFR—central nervous system—systemic lupus erythematosus	0.000166	0.00366	CbGeAlD
Methotrexate—PGD—nervous system—systemic lupus erythematosus	0.000166	0.00365	CbGeAlD
Methotrexate—PGD—central nervous system—systemic lupus erythematosus	0.00016	0.00352	CbGeAlD
Methotrexate—AOX1—lung—systemic lupus erythematosus	0.000158	0.00347	CbGeAlD
Methotrexate—SLC16A1—nervous system—systemic lupus erythematosus	0.000155	0.00341	CbGeAlD
Methotrexate—ABCC3—lung—systemic lupus erythematosus	0.000155	0.0034	CbGeAlD
Methotrexate—ABCC10—lung—systemic lupus erythematosus	0.000154	0.00338	CbGeAlD
Methotrexate—ABCC1—cortex of kidney—systemic lupus erythematosus	0.00015	0.00329	CbGeAlD
Methotrexate—SLC16A1—central nervous system—systemic lupus erythematosus	0.000149	0.00328	CbGeAlD
Methotrexate—ABCC4—tendon—systemic lupus erythematosus	0.000145	0.0032	CbGeAlD
Methotrexate—ABCG2—nephron tubule—systemic lupus erythematosus	0.000145	0.00318	CbGeAlD
Methotrexate—ABCC3—nervous system—systemic lupus erythematosus	0.000143	0.00315	CbGeAlD
Methotrexate—ABCC4—bone marrow—systemic lupus erythematosus	0.000141	0.0031	CbGeAlD
Methotrexate—ABCC2—tendon—systemic lupus erythematosus	0.000141	0.00309	CbGeAlD
Methotrexate—ABCB1—blood plasma—systemic lupus erythematosus	0.000138	0.00304	CbGeAlD
Methotrexate—ABCC3—central nervous system—systemic lupus erythematosus	0.000138	0.00303	CbGeAlD
Methotrexate—SLCO1A2—lung—systemic lupus erythematosus	0.000133	0.00291	CbGeAlD
Methotrexate—ABCC4—lung—systemic lupus erythematosus	0.000128	0.0028	CbGeAlD
Methotrexate—ABCC1—tendon—systemic lupus erythematosus	0.000124	0.00272	CbGeAlD
Methotrexate—SLCO1A2—nervous system—systemic lupus erythematosus	0.000123	0.0027	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—systemic lupus erythematosus	0.000118	0.0026	CbGeAlD
Methotrexate—ABCC4—nervous system—systemic lupus erythematosus	0.000118	0.0026	CbGeAlD
Methotrexate—SLC22A8—nervous system—systemic lupus erythematosus	0.000117	0.00258	CbGeAlD
Methotrexate—ATIC—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000116	0.077	CbGdCrCtD
Methotrexate—ABCC4—central nervous system—systemic lupus erythematosus	0.000114	0.0025	CbGeAlD
Methotrexate—SLC22A8—central nervous system—systemic lupus erythematosus	0.000113	0.00248	CbGeAlD
Methotrexate—ABCC1—lung—systemic lupus erythematosus	0.000109	0.00239	CbGeAlD
Methotrexate—ABCG2—bone marrow—systemic lupus erythematosus	9.95e-05	0.00219	CbGeAlD
Methotrexate—ABCG2—lung—systemic lupus erythematosus	9.01e-05	0.00198	CbGeAlD
Methotrexate—ABCB1—nephron tubule—systemic lupus erythematosus	7.14e-05	0.00157	CbGeAlD
Methotrexate—ABCB1—kidney—systemic lupus erythematosus	6.27e-05	0.00138	CbGeAlD
Methotrexate—ABCB1—cortex of kidney—systemic lupus erythematosus	6.11e-05	0.00134	CbGeAlD
Methotrexate—ABCB1—lymphoid tissue—systemic lupus erythematosus	5.39e-05	0.00118	CbGeAlD
Methotrexate—ABCB1—bone marrow—systemic lupus erythematosus	4.91e-05	0.00108	CbGeAlD
Methotrexate—ABCB1—lung—systemic lupus erythematosus	4.44e-05	0.000976	CbGeAlD
Methotrexate—TYMS—Flunisolide—Hydrocortisone—systemic lupus erythematosus	4.22e-05	0.028	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Hydrocortisone—systemic lupus erythematosus	4.18e-05	0.0277	CbGdCrCtD
Methotrexate—ABCB1—nervous system—systemic lupus erythematosus	4.12e-05	0.000904	CbGeAlD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—systemic lupus erythematosus	4.03e-05	0.0268	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—systemic lupus erythematosus	3.98e-05	0.0264	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—systemic lupus erythematosus	3.97e-05	0.0264	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—systemic lupus erythematosus	3.97e-05	0.0264	CbGdCrCtD
Methotrexate—ABCB1—central nervous system—systemic lupus erythematosus	3.96e-05	0.00087	CbGeAlD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—systemic lupus erythematosus	3.94e-05	0.0262	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.026	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—systemic lupus erythematosus	3.92e-05	0.026	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—systemic lupus erythematosus	3.88e-05	0.0258	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—systemic lupus erythematosus	3.88e-05	0.0257	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—systemic lupus erythematosus	3.88e-05	0.0257	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	3.84e-05	0.0255	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—systemic lupus erythematosus	3.83e-05	0.0254	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	3.78e-05	0.0251	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	3.78e-05	0.0251	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	3.7e-05	0.0245	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—systemic lupus erythematosus	3.68e-05	0.0244	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisone—systemic lupus erythematosus	3.63e-05	0.0241	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—systemic lupus erythematosus	3.63e-05	0.0241	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—systemic lupus erythematosus	3.6e-05	0.0239	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—systemic lupus erythematosus	3.59e-05	0.0239	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—systemic lupus erythematosus	3.57e-05	0.0237	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—systemic lupus erythematosus	3.57e-05	0.0237	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—systemic lupus erythematosus	3.55e-05	0.0235	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—systemic lupus erythematosus	3.51e-05	0.0233	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Triamcinolone—systemic lupus erythematosus	3.49e-05	0.0232	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Hydrocortisone—systemic lupus erythematosus	3.37e-05	0.0224	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Prednisone—systemic lupus erythematosus	3.31e-05	0.022	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—systemic lupus erythematosus	3.24e-05	0.0215	CbGdCrCtD
Methotrexate—TYMS—Danazol—Hydrocortisone—systemic lupus erythematosus	3.23e-05	0.0215	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Methylprednisolone—systemic lupus erythematosus	3.18e-05	0.0211	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—systemic lupus erythematosus	3.13e-05	0.0208	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Betamethasone—systemic lupus erythematosus	3.13e-05	0.0208	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.0203	CbGdCrCtD
Methotrexate—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	2.99e-05	0.000301	CcSEcCtD
Methotrexate—Rash—Azathioprine—systemic lupus erythematosus	2.99e-05	0.0003	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	2.99e-05	0.0003	CcSEcCtD
Methotrexate—Dermatitis—Azathioprine—systemic lupus erythematosus	2.98e-05	0.0003	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	2.98e-05	0.0003	CcSEcCtD
Methotrexate—Skin disorder—Hydrocortisone—systemic lupus erythematosus	2.98e-05	0.0003	CcSEcCtD
Methotrexate—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	2.98e-05	0.0003	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	2.98e-05	0.0003	CcSEcCtD
Methotrexate—Discomfort—Triamcinolone—systemic lupus erythematosus	2.98e-05	0.000299	CcSEcCtD
Methotrexate—Fatigue—Cyclosporine—systemic lupus erythematosus	2.98e-05	0.000299	CcSEcCtD
Methotrexate—Discomfort—Methylprednisolone—systemic lupus erythematosus	2.97e-05	0.000299	CcSEcCtD
Methotrexate—Headache—Azathioprine—systemic lupus erythematosus	2.97e-05	0.000298	CcSEcCtD
Methotrexate—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	2.97e-05	0.000298	CcSEcCtD
Methotrexate—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	2.96e-05	0.000298	CcSEcCtD
Methotrexate—Dizziness—Leflunomide—systemic lupus erythematosus	2.96e-05	0.000297	CcSEcCtD
Methotrexate—Pain—Cyclosporine—systemic lupus erythematosus	2.95e-05	0.000297	CcSEcCtD
Methotrexate—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	2.93e-05	0.000294	CcSEcCtD
Methotrexate—Anorexia—Hydrocortisone—systemic lupus erythematosus	2.92e-05	0.000294	CcSEcCtD
Methotrexate—Angiopathy—Prednisone—systemic lupus erythematosus	2.92e-05	0.000293	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	2.91e-05	0.000292	CcSEcCtD
Methotrexate—Confusional state—Methylprednisolone—systemic lupus erythematosus	2.91e-05	0.000292	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—systemic lupus erythematosus	2.91e-05	0.0193	CbGdCrCtD
Methotrexate—Immune system disorder—Prednisone—systemic lupus erythematosus	2.9e-05	0.000292	CcSEcCtD
Methotrexate—Malaise—Betamethasone—systemic lupus erythematosus	2.9e-05	0.000291	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—systemic lupus erythematosus	2.9e-05	0.000291	CcSEcCtD
Methotrexate—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	2.89e-05	0.00029	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—systemic lupus erythematosus	2.89e-05	0.00029	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—systemic lupus erythematosus	2.89e-05	0.00029	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	2.88e-05	0.00029	CcSEcCtD
Methotrexate—Pain—Mycophenolate mofetil—systemic lupus erythematosus	2.88e-05	0.000289	CcSEcCtD
Methotrexate—Infection—Triamcinolone—systemic lupus erythematosus	2.87e-05	0.000289	CcSEcCtD
Methotrexate—Hypotension—Hydrocortisone—systemic lupus erythematosus	2.87e-05	0.000288	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—systemic lupus erythematosus	2.86e-05	0.000288	CcSEcCtD
Methotrexate—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	2.84e-05	0.000286	CcSEcCtD
Methotrexate—Vomiting—Leflunomide—systemic lupus erythematosus	2.84e-05	0.000286	CcSEcCtD
Methotrexate—Insomnia—Prednisolone—systemic lupus erythematosus	2.84e-05	0.000286	CcSEcCtD
Methotrexate—Alopecia—Prednisone—systemic lupus erythematosus	2.84e-05	0.000285	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—systemic lupus erythematosus	2.84e-05	0.0188	CbGdCrCtD
Methotrexate—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	2.83e-05	0.000284	CcSEcCtD
Methotrexate—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	2.82e-05	0.000284	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—systemic lupus erythematosus	2.82e-05	0.000284	CcSEcCtD
Methotrexate—Rash—Leflunomide—systemic lupus erythematosus	2.82e-05	0.000284	CcSEcCtD
Methotrexate—Dermatitis—Leflunomide—systemic lupus erythematosus	2.82e-05	0.000283	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—systemic lupus erythematosus	2.82e-05	0.000283	CcSEcCtD
Methotrexate—Nausea—Azathioprine—systemic lupus erythematosus	2.81e-05	0.000283	CcSEcCtD
Methotrexate—Headache—Leflunomide—systemic lupus erythematosus	2.8e-05	0.000282	CcSEcCtD
Methotrexate—Skin disorder—Methylprednisolone—systemic lupus erythematosus	2.8e-05	0.000281	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—systemic lupus erythematosus	2.8e-05	0.000281	CcSEcCtD
Methotrexate—Erythema—Prednisone—systemic lupus erythematosus	2.8e-05	0.000281	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	2.8e-05	0.000281	CcSEcCtD
Methotrexate—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	2.79e-05	0.000281	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	2.79e-05	0.00028	CcSEcCtD
Methotrexate—TYMS—Danazol—Prednisone—systemic lupus erythematosus	2.78e-05	0.0185	CbGdCrCtD
Methotrexate—Convulsion—Dexamethasone—systemic lupus erythematosus	2.78e-05	0.00028	CcSEcCtD
Methotrexate—Convulsion—Betamethasone—systemic lupus erythematosus	2.78e-05	0.00028	CcSEcCtD
Methotrexate—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	2.78e-05	0.000279	CcSEcCtD
Methotrexate—Insomnia—Hydrocortisone—systemic lupus erythematosus	2.78e-05	0.000279	CcSEcCtD
Methotrexate—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	2.76e-05	0.000277	CcSEcCtD
Methotrexate—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	2.75e-05	0.000277	CcSEcCtD
Methotrexate—Urticaria—Cyclosporine—systemic lupus erythematosus	2.74e-05	0.000276	CcSEcCtD
Methotrexate—Myalgia—Dexamethasone—systemic lupus erythematosus	2.73e-05	0.000275	CcSEcCtD
Methotrexate—Myalgia—Betamethasone—systemic lupus erythematosus	2.73e-05	0.000275	CcSEcCtD
Methotrexate—Body temperature increased—Cyclosporine—systemic lupus erythematosus	2.73e-05	0.000274	CcSEcCtD
Methotrexate—Abdominal pain—Cyclosporine—systemic lupus erythematosus	2.73e-05	0.000274	CcSEcCtD
Methotrexate—Discomfort—Betamethasone—systemic lupus erythematosus	2.7e-05	0.000272	CcSEcCtD
Methotrexate—Discomfort—Dexamethasone—systemic lupus erythematosus	2.7e-05	0.000272	CcSEcCtD
Methotrexate—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	2.7e-05	0.000271	CcSEcCtD
Methotrexate—Hypotension—Methylprednisolone—systemic lupus erythematosus	2.69e-05	0.000271	CcSEcCtD
Methotrexate—Pain—Prednisolone—systemic lupus erythematosus	2.69e-05	0.00027	CcSEcCtD
Methotrexate—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	2.68e-05	0.000269	CcSEcCtD
Methotrexate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	2.67e-05	0.000268	CcSEcCtD
Methotrexate—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	2.66e-05	0.000268	CcSEcCtD
Methotrexate—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	2.66e-05	0.000268	CcSEcCtD
Methotrexate—Nausea—Leflunomide—systemic lupus erythematosus	2.66e-05	0.000267	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	2.65e-05	0.000266	CcSEcCtD
Methotrexate—Fatigue—Hydrocortisone—systemic lupus erythematosus	2.65e-05	0.000266	CcSEcCtD
Methotrexate—Vision blurred—Prednisone—systemic lupus erythematosus	2.64e-05	0.000265	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	2.63e-05	0.000265	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	2.63e-05	0.000264	CcSEcCtD
Methotrexate—Pain—Hydrocortisone—systemic lupus erythematosus	2.62e-05	0.000264	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.62e-05	0.000264	CcSEcCtD
Methotrexate—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.62e-05	0.000264	CcSEcCtD
Methotrexate—Insomnia—Triamcinolone—systemic lupus erythematosus	2.61e-05	0.000263	CcSEcCtD
Methotrexate—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.61e-05	0.000262	CcSEcCtD
Methotrexate—Infection—Betamethasone—systemic lupus erythematosus	2.6e-05	0.000262	CcSEcCtD
Methotrexate—Infection—Dexamethasone—systemic lupus erythematosus	2.6e-05	0.000262	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisone—systemic lupus erythematosus	2.6e-05	0.000261	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.59e-05	0.000261	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.59e-05	0.00026	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.59e-05	0.00026	CcSEcCtD
Methotrexate—Anaemia—Prednisone—systemic lupus erythematosus	2.59e-05	0.00026	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.58e-05	0.000259	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.57e-05	0.000258	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.57e-05	0.000258	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.57e-05	0.000258	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.57e-05	0.000258	CcSEcCtD
Methotrexate—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.54e-05	0.000256	CcSEcCtD
Methotrexate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.54e-05	0.000256	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.54e-05	0.000255	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.53e-05	0.000255	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.53e-05	0.000255	CcSEcCtD
Methotrexate—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.53e-05	0.000254	CcSEcCtD
Methotrexate—Malaise—Prednisone—systemic lupus erythematosus	2.52e-05	0.000254	CcSEcCtD
Methotrexate—Vertigo—Prednisone—systemic lupus erythematosus	2.51e-05	0.000253	CcSEcCtD
Methotrexate—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.51e-05	0.000252	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—systemic lupus erythematosus	2.5e-05	0.000251	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—systemic lupus erythematosus	2.5e-05	0.000251	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—systemic lupus erythematosus	2.5e-05	0.000251	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—systemic lupus erythematosus	2.49e-05	0.00025	CcSEcCtD
Methotrexate—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.49e-05	0.00025	CcSEcCtD
Methotrexate—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.48e-05	0.000249	CcSEcCtD
Methotrexate—Asthenia—Cyclosporine—systemic lupus erythematosus	2.48e-05	0.000249	CcSEcCtD
Methotrexate—Pain—Triamcinolone—systemic lupus erythematosus	2.47e-05	0.000248	CcSEcCtD
Methotrexate—Hypotension—Dexamethasone—systemic lupus erythematosus	2.45e-05	0.000246	CcSEcCtD
Methotrexate—Hypotension—Betamethasone—systemic lupus erythematosus	2.45e-05	0.000246	CcSEcCtD
Methotrexate—Pruritus—Cyclosporine—systemic lupus erythematosus	2.44e-05	0.000246	CcSEcCtD
Methotrexate—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.44e-05	0.000245	CcSEcCtD
Methotrexate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.43e-05	0.000244	CcSEcCtD
Methotrexate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.43e-05	0.000244	CcSEcCtD
Methotrexate—Convulsion—Prednisone—systemic lupus erythematosus	2.42e-05	0.000244	CcSEcCtD
Methotrexate—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.42e-05	0.000243	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.39e-05	0.00024	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.39e-05	0.00024	CcSEcCtD
Methotrexate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.38e-05	0.00024	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—systemic lupus erythematosus	2.38e-05	0.000239	CcSEcCtD
Methotrexate—Myalgia—Prednisone—systemic lupus erythematosus	2.38e-05	0.000239	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.38e-05	0.000239	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.38e-05	0.000239	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—systemic lupus erythematosus	2.37e-05	0.000238	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—systemic lupus erythematosus	2.37e-05	0.000238	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.36e-05	0.000238	CcSEcCtD
Methotrexate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.36e-05	0.000237	CcSEcCtD
Methotrexate—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.36e-05	0.000237	CcSEcCtD
Methotrexate—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.35e-05	0.000237	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.35e-05	0.000237	CcSEcCtD
Methotrexate—Discomfort—Prednisone—systemic lupus erythematosus	2.35e-05	0.000237	CcSEcCtD
Methotrexate—TYMS—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	2.32e-05	0.0154	CbGdCrCtD
Methotrexate—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.31e-05	0.000233	CcSEcCtD
Methotrexate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.31e-05	0.000232	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.31e-05	0.000232	CcSEcCtD
Methotrexate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.3e-05	0.000232	CcSEcCtD
Methotrexate—Urticaria—Triamcinolone—systemic lupus erythematosus	2.3e-05	0.000231	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.29e-05	0.00023	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.28e-05	0.00023	CcSEcCtD
Methotrexate—Dizziness—Cyclosporine—systemic lupus erythematosus	2.28e-05	0.000229	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.28e-05	0.000229	CcSEcCtD
Methotrexate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.28e-05	0.000229	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.28e-05	0.000229	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.28e-05	0.000229	CcSEcCtD
Methotrexate—Infection—Prednisone—systemic lupus erythematosus	2.27e-05	0.000228	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.26e-05	0.000227	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.26e-05	0.000227	CcSEcCtD
Methotrexate—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.26e-05	0.000227	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—systemic lupus erythematosus	2.26e-05	0.000227	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—systemic lupus erythematosus	2.26e-05	0.000227	CcSEcCtD
Methotrexate—Pain—Dexamethasone—systemic lupus erythematosus	2.24e-05	0.000225	CcSEcCtD
Methotrexate—Pain—Betamethasone—systemic lupus erythematosus	2.24e-05	0.000225	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.24e-05	0.000225	CcSEcCtD
Methotrexate—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.23e-05	0.000224	CcSEcCtD
Methotrexate—Skin disorder—Prednisone—systemic lupus erythematosus	2.22e-05	0.000223	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.21e-05	0.000222	CcSEcCtD
Methotrexate—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.2e-05	0.000221	CcSEcCtD
Methotrexate—Vomiting—Cyclosporine—systemic lupus erythematosus	2.2e-05	0.000221	CcSEcCtD
Methotrexate—Rash—Cyclosporine—systemic lupus erythematosus	2.18e-05	0.000219	CcSEcCtD
Methotrexate—Anorexia—Prednisone—systemic lupus erythematosus	2.18e-05	0.000219	CcSEcCtD
Methotrexate—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.17e-05	0.000219	CcSEcCtD
Methotrexate—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.17e-05	0.000218	CcSEcCtD
Methotrexate—Headache—Cyclosporine—systemic lupus erythematosus	2.16e-05	0.000217	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.16e-05	0.000217	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.16e-05	0.000217	CcSEcCtD
Methotrexate—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.14e-05	0.000215	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.14e-05	0.000215	CcSEcCtD
Methotrexate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.14e-05	0.000215	CcSEcCtD
Methotrexate—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.13e-05	0.000214	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.12e-05	0.000213	CcSEcCtD
Methotrexate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.12e-05	0.000213	CcSEcCtD
Methotrexate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.12e-05	0.000213	CcSEcCtD
Methotrexate—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.11e-05	0.000212	CcSEcCtD
Methotrexate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.1e-05	0.000211	CcSEcCtD
Methotrexate—Urticaria—Betamethasone—systemic lupus erythematosus	2.08e-05	0.000209	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—systemic lupus erythematosus	2.08e-05	0.000209	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.08e-05	0.000209	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—systemic lupus erythematosus	2.08e-05	0.000209	CcSEcCtD
Methotrexate—Asthenia—Triamcinolone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.07e-05	0.000208	CcSEcCtD
Methotrexate—Insomnia—Prednisone—systemic lupus erythematosus	2.06e-05	0.000208	CcSEcCtD
Methotrexate—Nausea—Cyclosporine—systemic lupus erythematosus	2.05e-05	0.000206	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—systemic lupus erythematosus	2.05e-05	0.000206	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—systemic lupus erythematosus	2.04e-05	0.000205	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.04e-05	0.000205	CcSEcCtD
Methotrexate—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.03e-05	0.000204	CcSEcCtD
Methotrexate—Dyspepsia—Prednisone—systemic lupus erythematosus	2.01e-05	0.000202	CcSEcCtD
Methotrexate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2e-05	0.000201	CcSEcCtD
Methotrexate—Decreased appetite—Prednisone—systemic lupus erythematosus	1.98e-05	0.000199	CcSEcCtD
Methotrexate—Rash—Prednisolone—systemic lupus erythematosus	1.98e-05	0.000199	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—systemic lupus erythematosus	1.98e-05	0.000199	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	1.97e-05	0.000198	CcSEcCtD
Methotrexate—Fatigue—Prednisone—systemic lupus erythematosus	1.97e-05	0.000198	CcSEcCtD
Methotrexate—Headache—Prednisolone—systemic lupus erythematosus	1.97e-05	0.000198	CcSEcCtD
Methotrexate—Vomiting—Hydrocortisone—systemic lupus erythematosus	1.95e-05	0.000196	CcSEcCtD
Methotrexate—Rash—Hydrocortisone—systemic lupus erythematosus	1.93e-05	0.000194	CcSEcCtD
Methotrexate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	1.93e-05	0.000194	CcSEcCtD
Methotrexate—Headache—Hydrocortisone—systemic lupus erythematosus	1.92e-05	0.000193	CcSEcCtD
Methotrexate—Dizziness—Triamcinolone—systemic lupus erythematosus	1.91e-05	0.000192	CcSEcCtD
Methotrexate—Dizziness—Methylprednisolone—systemic lupus erythematosus	1.91e-05	0.000192	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—systemic lupus erythematosus	1.88e-05	0.000189	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—systemic lupus erythematosus	1.88e-05	0.000189	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—systemic lupus erythematosus	1.88e-05	0.000189	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	1.87e-05	0.000188	CcSEcCtD
Methotrexate—Nausea—Prednisolone—systemic lupus erythematosus	1.87e-05	0.000188	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—systemic lupus erythematosus	1.85e-05	0.000186	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—systemic lupus erythematosus	1.85e-05	0.000186	CcSEcCtD
Methotrexate—Vomiting—Triamcinolone—systemic lupus erythematosus	1.84e-05	0.000185	CcSEcCtD
Methotrexate—Vomiting—Methylprednisolone—systemic lupus erythematosus	1.83e-05	0.000184	CcSEcCtD
Methotrexate—Nausea—Hydrocortisone—systemic lupus erythematosus	1.82e-05	0.000183	CcSEcCtD
Methotrexate—Rash—Triamcinolone—systemic lupus erythematosus	1.82e-05	0.000183	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—systemic lupus erythematosus	1.82e-05	0.000183	CcSEcCtD
Methotrexate—Rash—Methylprednisolone—systemic lupus erythematosus	1.82e-05	0.000183	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	1.82e-05	0.000183	CcSEcCtD
Methotrexate—Urticaria—Prednisone—systemic lupus erythematosus	1.81e-05	0.000182	CcSEcCtD
Methotrexate—Headache—Triamcinolone—systemic lupus erythematosus	1.81e-05	0.000182	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—systemic lupus erythematosus	1.81e-05	0.000182	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—systemic lupus erythematosus	1.8e-05	0.000181	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—systemic lupus erythematosus	1.8e-05	0.000181	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	1.79e-05	0.00018	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—systemic lupus erythematosus	1.79e-05	0.00018	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—systemic lupus erythematosus	1.73e-05	0.000174	CcSEcCtD
Methotrexate—Dizziness—Dexamethasone—systemic lupus erythematosus	1.73e-05	0.000174	CcSEcCtD
Methotrexate—Nausea—Triamcinolone—systemic lupus erythematosus	1.72e-05	0.000172	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—systemic lupus erythematosus	1.71e-05	0.000172	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.68e-05	0.000169	CcSEcCtD
Methotrexate—Vomiting—Dexamethasone—systemic lupus erythematosus	1.67e-05	0.000168	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—systemic lupus erythematosus	1.67e-05	0.000168	CcSEcCtD
Methotrexate—Rash—Betamethasone—systemic lupus erythematosus	1.65e-05	0.000166	CcSEcCtD
Methotrexate—Rash—Dexamethasone—systemic lupus erythematosus	1.65e-05	0.000166	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.65e-05	0.000166	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—systemic lupus erythematosus	1.65e-05	0.000166	CcSEcCtD
Methotrexate—Headache—Dexamethasone—systemic lupus erythematosus	1.64e-05	0.000165	CcSEcCtD
Methotrexate—Headache—Betamethasone—systemic lupus erythematosus	1.64e-05	0.000165	CcSEcCtD
Methotrexate—Asthenia—Prednisone—systemic lupus erythematosus	1.64e-05	0.000165	CcSEcCtD
Methotrexate—Pruritus—Prednisone—systemic lupus erythematosus	1.62e-05	0.000162	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—systemic lupus erythematosus	1.56e-05	0.000157	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—systemic lupus erythematosus	1.56e-05	0.000157	CcSEcCtD
Methotrexate—Nausea—Betamethasone—systemic lupus erythematosus	1.56e-05	0.000157	CcSEcCtD
Methotrexate—Dizziness—Prednisone—systemic lupus erythematosus	1.51e-05	0.000152	CcSEcCtD
Methotrexate—Vomiting—Prednisone—systemic lupus erythematosus	1.45e-05	0.000146	CcSEcCtD
Methotrexate—Rash—Prednisone—systemic lupus erythematosus	1.44e-05	0.000145	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—systemic lupus erythematosus	1.44e-05	0.000145	CcSEcCtD
Methotrexate—Headache—Prednisone—systemic lupus erythematosus	1.43e-05	0.000144	CcSEcCtD
Methotrexate—Nausea—Prednisone—systemic lupus erythematosus	1.36e-05	0.000136	CcSEcCtD
Methotrexate—SLC46A1—Disease—CD4—systemic lupus erythematosus	8.61e-06	0.00031	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—systemic lupus erythematosus	8.55e-06	0.000308	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—systemic lupus erythematosus	8.55e-06	0.000308	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.53e-06	0.000307	CbGpPWpGaD
Methotrexate—AOX1—Disease—JAK1—systemic lupus erythematosus	8.53e-06	0.000307	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HIST2H2AC—systemic lupus erythematosus	8.52e-06	0.000307	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—RXRA—systemic lupus erythematosus	8.49e-06	0.000306	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN1B—systemic lupus erythematosus	8.46e-06	0.000305	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—LYN—systemic lupus erythematosus	8.46e-06	0.000305	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARG—systemic lupus erythematosus	8.32e-06	0.0003	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	8.31e-06	0.000299	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CSK—systemic lupus erythematosus	8.3e-06	0.000299	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	8.3e-06	0.000299	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CCR5—systemic lupus erythematosus	8.27e-06	0.000298	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	8.26e-06	0.000297	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	8.21e-06	0.000296	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—systemic lupus erythematosus	8.18e-06	0.000295	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	8.14e-06	0.000293	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CDKN1B—systemic lupus erythematosus	8.09e-06	0.000292	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	8.08e-06	0.000291	CbGpPWpGaD
Methotrexate—AOX1—Disease—CCR5—systemic lupus erythematosus	8.08e-06	0.000291	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—systemic lupus erythematosus	7.99e-06	0.000288	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	7.96e-06	0.000287	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—systemic lupus erythematosus	7.93e-06	0.000286	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.91e-06	0.000285	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.89e-06	0.000284	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.88e-06	0.000284	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—systemic lupus erythematosus	7.87e-06	0.000284	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—systemic lupus erythematosus	7.82e-06	0.000282	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—systemic lupus erythematosus	7.82e-06	0.000282	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—CDKN1A—systemic lupus erythematosus	7.81e-06	0.000281	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD247—systemic lupus erythematosus	7.8e-06	0.000281	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NAT2—systemic lupus erythematosus	7.8e-06	0.000281	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	7.77e-06	0.00028	CbGpPWpGaD
Methotrexate—DHFR—Disease—JAK1—systemic lupus erythematosus	7.76e-06	0.00028	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—RXRA—systemic lupus erythematosus	7.73e-06	0.000278	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—EP300—systemic lupus erythematosus	7.64e-06	0.000275	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—EP300—systemic lupus erythematosus	7.64e-06	0.000275	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	7.62e-06	0.000275	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	7.6e-06	0.000274	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NCF2—systemic lupus erythematosus	7.59e-06	0.000274	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.5e-06	0.00027	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—systemic lupus erythematosus	7.48e-06	0.00027	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CDKN1A—systemic lupus erythematosus	7.47e-06	0.000269	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—EP300—systemic lupus erythematosus	7.43e-06	0.000268	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	7.41e-06	0.000267	CbGpPWpGaD
Methotrexate—PGD—Disease—CDKN1B—systemic lupus erythematosus	7.4e-06	0.000267	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN1B—systemic lupus erythematosus	7.38e-06	0.000266	CbGpPWpGaD
Methotrexate—DHFR—Disease—CCR5—systemic lupus erythematosus	7.35e-06	0.000265	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—systemic lupus erythematosus	7.35e-06	0.000265	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	7.25e-06	0.000261	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—EP300—systemic lupus erythematosus	7.17e-06	0.000258	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—systemic lupus erythematosus	7.16e-06	0.000258	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—systemic lupus erythematosus	7.16e-06	0.000258	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.11e-06	0.000256	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EP300—systemic lupus erythematosus	7.11e-06	0.000256	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—RXRA—systemic lupus erythematosus	7.04e-06	0.000254	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—systemic lupus erythematosus	7.03e-06	0.000253	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—systemic lupus erythematosus	7.03e-06	0.000253	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.9e-06	0.000249	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.89e-06	0.000248	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	6.86e-06	0.000247	CbGpPWpGaD
Methotrexate—PGD—Disease—CDKN1A—systemic lupus erythematosus	6.83e-06	0.000246	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—CDKN1A—systemic lupus erythematosus	6.81e-06	0.000245	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD80—systemic lupus erythematosus	6.8e-06	0.000245	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—VEGFA—systemic lupus erythematosus	6.79e-06	0.000245	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.76e-06	0.000244	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—RXRA—systemic lupus erythematosus	6.74e-06	0.000243	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD80—systemic lupus erythematosus	6.65e-06	0.000239	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.63e-06	0.000239	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—systemic lupus erythematosus	6.55e-06	0.000236	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	6.52e-06	0.000235	CbGpPWpGaD
Methotrexate—PGD—Disease—EP300—systemic lupus erythematosus	6.5e-06	0.000234	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—EP300—systemic lupus erythematosus	6.48e-06	0.000234	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.42e-06	0.000231	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.36e-06	0.000229	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	6.35e-06	0.000229	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—systemic lupus erythematosus	6.23e-06	0.000225	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.22e-06	0.000224	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.2e-06	0.000223	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.19e-06	0.000223	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	6.18e-06	0.000223	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—systemic lupus erythematosus	6.18e-06	0.000223	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD80—systemic lupus erythematosus	6.05e-06	0.000218	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—systemic lupus erythematosus	5.98e-06	0.000215	CbGpPWpGaD
Methotrexate—ABCC1—Disease—JUNB—systemic lupus erythematosus	5.96e-06	0.000215	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—systemic lupus erythematosus	5.96e-06	0.000215	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—EP300—systemic lupus erythematosus	5.95e-06	0.000214	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.89e-06	0.000212	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.89e-06	0.000212	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TYK2—systemic lupus erythematosus	5.74e-06	0.000207	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.74e-06	0.000207	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—systemic lupus erythematosus	5.65e-06	0.000204	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—systemic lupus erythematosus	5.64e-06	0.000203	CbGpPWpGaD
Methotrexate—AOX1—Disease—TYK2—systemic lupus erythematosus	5.61e-06	0.000202	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—RXRA—systemic lupus erythematosus	5.58e-06	0.000201	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.57e-06	0.000201	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	5.56e-06	0.0002	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.54e-06	0.000199	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—systemic lupus erythematosus	5.51e-06	0.000198	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PPARG—systemic lupus erythematosus	5.49e-06	0.000198	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PRL—systemic lupus erythematosus	5.49e-06	0.000198	CbGpPWpGaD
Methotrexate—PGD—Metabolism—EP300—systemic lupus erythematosus	5.44e-06	0.000196	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.42e-06	0.000195	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.36e-06	0.000193	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARG—systemic lupus erythematosus	5.36e-06	0.000193	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—EP300—systemic lupus erythematosus	5.35e-06	0.000193	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.33e-06	0.000192	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.3e-06	0.000191	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.3e-06	0.000191	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	5.26e-06	0.00019	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	5.23e-06	0.000188	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—systemic lupus erythematosus	5.19e-06	0.000187	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.18e-06	0.000187	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—systemic lupus erythematosus	5.16e-06	0.000186	CbGpPWpGaD
Methotrexate—DHFR—Disease—TYK2—systemic lupus erythematosus	5.1e-06	0.000184	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—systemic lupus erythematosus	5.07e-06	0.000183	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.07e-06	0.000183	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VEGFA—systemic lupus erythematosus	5.06e-06	0.000182	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.04e-06	0.000181	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—systemic lupus erythematosus	5.04e-06	0.000181	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—systemic lupus erythematosus	5.01e-06	0.000181	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—systemic lupus erythematosus	4.94e-06	0.000178	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—JAK1—systemic lupus erythematosus	4.92e-06	0.000177	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN1B—systemic lupus erythematosus	4.88e-06	0.000176	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARG—systemic lupus erythematosus	4.88e-06	0.000176	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.88e-06	0.000176	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—RXRA—systemic lupus erythematosus	4.86e-06	0.000175	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.86e-06	0.000175	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—systemic lupus erythematosus	4.82e-06	0.000174	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN1B—systemic lupus erythematosus	4.77e-06	0.000172	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—systemic lupus erythematosus	4.72e-06	0.00017	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.66e-06	0.000168	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—systemic lupus erythematosus	4.66e-06	0.000168	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—systemic lupus erythematosus	4.65e-06	0.000167	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.63e-06	0.000167	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	4.62e-06	0.000166	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—systemic lupus erythematosus	4.62e-06	0.000166	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—systemic lupus erythematosus	4.61e-06	0.000166	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	4.6e-06	0.000166	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—systemic lupus erythematosus	4.58e-06	0.000165	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN1A—systemic lupus erythematosus	4.51e-06	0.000162	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.51e-06	0.000162	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.44e-06	0.00016	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—systemic lupus erythematosus	4.44e-06	0.00016	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.44e-06	0.00016	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN1A—systemic lupus erythematosus	4.4e-06	0.000159	CbGpPWpGaD
Methotrexate—ABCC1—Disease—JAK1—systemic lupus erythematosus	4.39e-06	0.000158	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—systemic lupus erythematosus	4.39e-06	0.000158	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	4.38e-06	0.000158	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	4.37e-06	0.000158	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1B—systemic lupus erythematosus	4.34e-06	0.000156	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—systemic lupus erythematosus	4.32e-06	0.000156	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EP300—systemic lupus erythematosus	4.29e-06	0.000155	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—systemic lupus erythematosus	4.26e-06	0.000153	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—systemic lupus erythematosus	4.26e-06	0.000153	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NAT2—systemic lupus erythematosus	4.23e-06	0.000153	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—systemic lupus erythematosus	4.22e-06	0.000152	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—systemic lupus erythematosus	4.2e-06	0.000151	CbGpPWpGaD
Methotrexate—AOX1—Disease—EP300—systemic lupus erythematosus	4.19e-06	0.000151	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—systemic lupus erythematosus	4.16e-06	0.00015	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	4.15e-06	0.00015	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	4.08e-06	0.000147	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.06e-06	0.000146	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	4.02e-06	0.000145	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1A—systemic lupus erythematosus	4e-06	0.000144	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—F2—systemic lupus erythematosus	4e-06	0.000144	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—systemic lupus erythematosus	3.99e-06	0.000144	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	3.9e-06	0.000141	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.85e-06	0.000139	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	3.85e-06	0.000139	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—systemic lupus erythematosus	3.84e-06	0.000138	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—systemic lupus erythematosus	3.83e-06	0.000138	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—systemic lupus erythematosus	3.82e-06	0.000138	CbGpPWpGaD
Methotrexate—DHFR—Disease—EP300—systemic lupus erythematosus	3.81e-06	0.000137	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.75e-06	0.000135	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—systemic lupus erythematosus	3.73e-06	0.000134	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	3.71e-06	0.000134	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—systemic lupus erythematosus	3.66e-06	0.000132	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—systemic lupus erythematosus	3.64e-06	0.000131	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—EP300—systemic lupus erythematosus	3.59e-06	0.000129	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—systemic lupus erythematosus	3.52e-06	0.000127	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	3.51e-06	0.000127	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—EP300—systemic lupus erythematosus	3.51e-06	0.000126	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—systemic lupus erythematosus	3.49e-06	0.000126	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD80—systemic lupus erythematosus	3.42e-06	0.000123	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.37e-06	0.000121	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	3.36e-06	0.000121	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—systemic lupus erythematosus	3.35e-06	0.000121	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—systemic lupus erythematosus	3.31e-06	0.000119	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—EP300—systemic lupus erythematosus	3.19e-06	0.000115	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—systemic lupus erythematosus	3.18e-06	0.000115	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—systemic lupus erythematosus	3.17e-06	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	3.07e-06	0.000111	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—systemic lupus erythematosus	3.07e-06	0.000111	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—systemic lupus erythematosus	3.03e-06	0.000109	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—EP300—systemic lupus erythematosus	2.91e-06	0.000105	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TYK2—systemic lupus erythematosus	2.89e-06	0.000104	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—systemic lupus erythematosus	2.84e-06	0.000102	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—systemic lupus erythematosus	2.81e-06	0.000101	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—EP300—systemic lupus erythematosus	2.78e-06	0.0001	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—systemic lupus erythematosus	2.77e-06	9.99e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	2.76e-06	9.95e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—systemic lupus erythematosus	2.76e-06	9.94e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—systemic lupus erythematosus	2.74e-06	9.89e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.7e-06	9.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.65e-06	9.54e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—systemic lupus erythematosus	2.64e-06	9.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	2.62e-06	9.45e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—systemic lupus erythematosus	2.61e-06	9.41e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—systemic lupus erythematosus	2.59e-06	9.34e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	2.55e-06	9.21e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.52e-06	9.09e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—systemic lupus erythematosus	2.5e-06	8.99e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—systemic lupus erythematosus	2.48e-06	8.94e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	2.46e-06	8.85e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	2.43e-06	8.75e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.42e-06	8.72e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.41e-06	8.7e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	2.37e-06	8.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.37e-06	8.55e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	2.36e-06	8.5e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—EP300—systemic lupus erythematosus	2.31e-06	8.31e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.29e-06	8.25e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	2.27e-06	8.17e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	2.26e-06	8.13e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.2e-06	7.93e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—systemic lupus erythematosus	2.18e-06	7.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	2.17e-06	7.83e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EP300—systemic lupus erythematosus	2.16e-06	7.77e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.1e-06	7.58e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	2.09e-06	7.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.08e-06	7.5e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	2.06e-06	7.44e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—EP300—systemic lupus erythematosus	2.01e-06	7.23e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	1.91e-06	6.89e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—systemic lupus erythematosus	1.87e-06	6.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—EP300—systemic lupus erythematosus	1.81e-06	6.51e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	1.72e-06	6.18e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—EP300—systemic lupus erythematosus	1.59e-06	5.73e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.5e-06	5.4e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—systemic lupus erythematosus	1.41e-06	5.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.31e-06	4.73e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.29e-06	4.65e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.18e-06	4.26e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.18e-06	4.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.13e-06	4.07e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.03e-06	3.72e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—EP300—systemic lupus erythematosus	9.81e-07	3.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—EP300—systemic lupus erythematosus	8.59e-07	3.1e-05	CbGpPWpGaD
